Biomarker Lens

Biomarkers · Chemical

Ethosuximide (Zarontin), Serum

Understand what Ethosuximide (Zarontin), Serum signals

Primary unit
ug/mL
LOINC codes
3616-0
Commercial laboratory assays
2

We have not added a physiological summary for this biomarker yet. Compare the commercial laboratory assays and population reference ranges below.

Compare commercial laboratory assays for Ethosuximide (Zarontin), Serum

Check orderable catalog codes, specimen types, fasting requirements, and demographic reference ranges across laboratories.

Ethosuximide

Laboratory
Quest Diagnostics
Test code
214
Specimen
Serum
Fasting
Not stated
LOINC
3616-0
Turnaround
Set up: Mon-Sat

Laboratory assay overview

Ethosuximide is an anticonvulsant used to treat seizures. Ethosuximide levels are monitored to assure adequate therapeutic levels are achieved and to avoid toxicity.

View complete laboratory reference notes

40-100 mg/L

Quest Diagnostics test directory, test code 214

Ethosuximide, Serum or Plasma

Laboratory
Labcorp
Test code
007443
Specimen
Serum
Fasting
Not stated
LOINC
3616-0
Turnaround
1 - 3 days

Laboratory assay overview

Evaluate toxicity; monitor therapeutic levels

View complete laboratory reference notes

Therapeutic: 40−100 μg/mL

Labcorp test directory, test code 007443

Verify these ranges and sources

We compile every detail above directly from named laboratory directories and published clinical studies. Laboratories calculate standard reference intervals from the statistical distribution of tested populations for a specific assay method and demographic group, rather than setting universal optimal targets.

Always review your personal lab results with a licensed clinician, or track your lab history and health goals in Aumnivida.

Spotted an error? Email hello@biomarkerlens.com with the page URL and the primary source that corrects the entry.